Lamotrigine Tablet, Extended Release shortage
To Be Discontinued 6 presentations · 1 manufacturers · first FDA posting 2026-04-29 · last update 2026-04-29
Manufacturers: Par Health, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/29/2026 Updated 04/29/2026 Discontinued 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/29/2026 Updated 04/29/2026 Discontinued 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/29/2026 Updated 04/29/2026 Discontinued 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/29/2026 Updated 04/29/2026 Discontinued 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/29/2026 Updated 04/29/2026 Discontinued 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/29/2026 Updated 04/29/2026 Discontinued 04/29/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)